ROR1-based immunomagnetic protocol allows efficient separation of CLL and healthy B cells

• Autoři: KOTAŠKOVÁ Jana; PAVLOVÁ Šárka; GREIF Igor; STEHLÍKOVÁ Olga; PLEVOVÁ Karla; JANOVSKÁ Pavlína; BRYCHTOVÁ Yvona; DOUBEK Michael; POSPÍŠILOVÁ Šárka; BRYJA Vítězslav
• Rok publikování: 2016
• Druh: Článek v odborném periodiku
• Časopis / Zdroj: British Journal of Haematology
• Fakulta / Pracoviště MU: Přírodovědecká fakulta
• www: http://onlinelibrary.wiley.com/doi/10.1111/bjh.13848/epdf
• Doi: http://dx.doi.org/10.1111/bjh.13848
• Obor: Onkologie a hematologie
• Klíčová slova: ROR1; cell isolation; chronic lymphocytic leukaemia; complete remission

Přiložené soubory

• 1341575.pdf

• Popis: Chronic lymphocytic leukaemia (CLL) is the most common leukaemia among adults in the Western world. This lymphoproliferative disorder is defined by the presence of at least 5 9 106 clonal lymphocytes/ml peripheral blood (Hallek,2015). The biggest clinical challenge is the fact that CLL eradication by any available therapy, apart from allogeneic stem cell transplantation, fails to cure the disease, inducing only temporary disease remission, i.e., when the disease does not manifest clinically but CLL cells still persist in the body. During this phase a population of CLL cells often slowly re-expands to trigger CLL relapse. The relapse is often based on the poorly understood but clinically important process of therapy-driven selection of more aggressive CLL subclones (Malcikova et al, 2015).

Související projekty

• Analýza Wnt/PCP jako nástroj pro lepší management chronické lymfocytární leukémie